Mounjaro becomes India’s top-selling GLP-1 drug as diabetes, weight-loss medicines surge

Mounjaro, the blockbuster diabetes and weight-loss drug from Eli Lilly, has emerged as the biggest-selling brand in India’s rapidly expanding GLP-1 medicines market, underscoring the growing demand for newer treatments for diabetes and obesity.